RxDoctor Payments Data

Gary Blum, MD

Hand Surgery · Honolulu, HINPI 1912102500

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,940 of the $3,054 with a category attached, or 63.5%. Arthrex accounts for 70.5% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2019 at $1,393 and has fallen 95.6% since, to $61 in 2023.

$3,054in general payments, 2019–2025

Across 36 payments — averaging $84.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$2K
  • Impactortho, Inc.$390
  • Sportstek Medical, Inc$156
  • Bioventus LLC$145
  • Medacta USA, Inc.$131
  • Elevate Surgical Co$61
  • plus $17 from 1 others

What the payments were for

  • Travel & lodging$1,11436%
  • Food & beverage$1,94064%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Arthrex22$2,154
Impactortho, Inc.3$390
Sportstek Medical, Inc2$156
Bioventus LLC6$145
Medacta USA, Inc.1$131
Elevate Surgical Co1$61
Ferring Pharmaceuticals Inc.1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few hand surgery providers in Hawaiito place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$179,147
Medicare patients
1,261
Services billed
2,458

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Naproxen54$358

Paid to pharmacies, not to this prescriber.

Other hand surgery in Honolulu

See the full list for Hawaii

Where these figures come from

Is this you, or does something look wrong? →